Related Experiment Video
Updated: Jun 12, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Ocular artery thrombosis as an initial presentation of a prothrombin G20210A mutation
C Parc1, E Tiberghien, V Pierre-Kahn
1Service d'ophtalmologie, hôpital Foch, 40, rue Worth, 92150 Suresnes, France. c.parc@hopital-foch.org
Abstract:
The G20210A mutation in the prothrombin gene is an established risk factor for venous thrombosis. There is controversy as to the role played by this mutation in arterial thrombotic disease. We present the case of a 56-year-old man who presented with a central retinal artery occlusion of the left eye. Evaluation revealed hypercholesterolemia, smoking, and heterozygosity for the prothrombin G20210A mutation. The literature concerning hereditary thrombophilia and retinal artery occlusion was reviewed. The synergistic effect of multiple risk factors is emphasized. Screening for hereditary thrombophilia should be considered, regardless of patient age. The prothrombin G20210A mutation may be associated with central retinal artery occlusion.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Glaucoma: Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
